Akira Kawamura to Coronary Artery Disease
This is a "connection" page, showing publications Akira Kawamura has written about Coronary Artery Disease.
Connection Strength
1.520
-
Kawamura A, Miura S, Murayama T, Iwata A, Zhang B, Nishikawa H, Tsuchiya Y, Matsuo K, Tsuji E, Saku K. Increased expression of monocyte CD11a and intracellular adhesion molecule-1 in patients with initial atherosclerotic coronary stenosis. Circ J. 2004 Jan; 68(1):6-10.
Score: 0.210
-
Kawamura A, Miura S, Fujino M, Nishikawa H, Matsuo Y, Tanigawa H, Tomita S, Tsuchiya Y, Matsuo K, Saku K. CXCR3 chemokine receptor-plasma IP10 interaction in patients with coronary artery disease. Circ J. 2003 Oct; 67(10):851-4.
Score: 0.207
-
Nakamura M, Ike A, Kato Y, Futami M, Kuwano T, Sugihara M, Iwata A, Kawamura A, Suematsu Y, Miura SI. Differences in lesion characteristics and patient background associated with the medium-term clinical outcomes of bare-metal and first-, second- and third-generation drug-eluting stents. Heart Vessels. 2021 Feb; 36(2):211-222.
Score: 0.167
-
Koyoshi R, Hitaka-Yoshimine Y, Shiga Y, Kuwano T, Sugihara M, Ike A, Iwata A, Sako H, Morito N, Kawamura A, Miura SI. Associations between microalbuminuria and parameters of flow-mediated vasodilatation obtained by continuous measurement approaches. Clin Exp Hypertens. 2018; 40(8):715-720.
Score: 0.139
-
Matsuoka Y, Ike A, Ogawa M, Gondo K, Shirai K, Sugihara M, Nose D, Nishikawa H, Iwata A, Kawamura A, Mori K, Zhang B, Yasunaga S, Miura SI, Saku K. Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry. J Cardiol. 2018 03; 71(3):259-267.
Score: 0.137
-
Iwata A, Miura S, Tanaka T, Ike A, Sugihara M, Nishikawa H, Kawamura A, Saku K. Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin. Coron Artery Dis. 2012 Aug; 23(5):315-21.
Score: 0.095
-
Shiga Y, Miura S, Mitsutake R, Kawamura A, Uehara Y, Saku K. Significance of serum high-density lipoprotein cholesterol levels for diagnosis of coronary stenosis as determined by MDCT in patients with suspected coronary artery disease. J Atheroscler Thromb. 2010 Aug 31; 17(8):870-8.
Score: 0.082
-
Fukuda Y, Miura S, Zhang B, Iwata A, Kawamura A, Nishikawa H, Shirai K, Saku K. Significance of urinary liver-fatty acid-binding protein in cardiac catheterization in patients with coronary artery disease. Intern Med. 2009; 48(19):1731-7.
Score: 0.078
-
Takamiya Y, Miura S, Kawamura A, Tanigawa H, Zhang B, Iwata A, Nishikawa H, Matsuo K, Shirai K, Saku K. Intensive LOwering of BlOod pressure and low-density lipoprotein ChOlesterol with statin theraPy (LOBOCOP) may improve neointimal formation after coronary stenting in patients with coronary artery disease. Coron Artery Dis. 2009 Jun; 20(4):288-94.
Score: 0.076
-
Iwata A, Miura S, Mori K, Kawamura A, Nishikawa H, Saku K. Associations between metabolic factors and coronary plaque growth or arterial remodeling as assessed by intravascular ultrasound in patients with stable angina. Hypertens Res. 2008 Oct; 31(10):1879-86.
Score: 0.073
-
Mitsutake R, Miura S, Okamura K, Niimura H, Kawamura A, Saku K. Successful intensive lipid-lowering therapy using atorvastatin stabilizes coronary artery plaque as assessed by multi-detector row computed tomography. Intern Med. 2007; 46(12):859-63.
Score: 0.067
-
Imaizumi S, Miura S, Nishikawa H, Iwata A, Zhang B, Kawamura A, Tsuchiya Y, Kumagai K, Matsuo K, Saku K. Angiotensin II type 1 receptor blockers do not promote coronary collateral circulation in patients with coronary artery disease. Hypertens Res. 2006 Mar; 29(3):135-41.
Score: 0.061
-
Nishikawa H, Miura S, Shimomura H, Kawamura A, Tsujita K, Shirai K, Matsuo K, Arai H, Saku K. Effect of statin on restenosis after radius stent implantation in patients with acute coronary syndrome. J Atheroscler Thromb. 2005; 12(6):302-6.
Score: 0.056
-
Gondo K, Ike A, Ogawa M, Shirai K, Sugihara M, Nishikawa H, Iwata A, Kawamura A, Mori K, Zhang B, Miura S, Yasunaga S, Saku K. Is a bare-metal stent still useful for improving the outcome of percutaneous coronary intervention? From the FU-Registry. J Cardiol. 2017 04; 69(4):652-659.
Score: 0.031
-
Kuwano T, Miura S, Shirai K, Ike A, Mori K, Shimizu T, Zhang B, Iwata A, Nishikawa H, Kawamura A, Saku K. Serum levels of bilirubin as an independent predictor of coronary in-stent restenosis: a new look at an old molecule. J Atheroscler Thromb. 2011; 18(7):574-83.
Score: 0.022
-
Miura S, Kawamura A, Saku K. Efficacy and safety of drug-eluting stents in long-term follow-up. Intern Med. 2008; 47(11):987-8.
Score: 0.018